VHIR Report

< Back

Report sent on 11/06/2021 with indicators according to ICS requisites.

Catalan Health Institute (ICS) is the largest public health service company in Spain and is affiliated to the Department of Health of the Generalitat de Catalunya. The Catalan Health Institute is made up of eight hospitals and about 300 primary care teams. It provides healthcare to almost six million users, a figure that represents 75% of the total number of people with healthcare rights in Catalonia.

Inputs

Competitive projects Principal Investigators
2019
Total CO-PI’s ICS staff % ICS total
203 15 142 69.95%
2020
Total CO-PI’s ICS staff % ICS total
206 3 144 69.90%
Commercial projects Principal Investigators
2019
Total NIPRC* ICS staff % ICS total
171 118 92 77.97%
2020
Total NIPRC* ICS staff % ICS total
181 121 94 77.69%

*NIPRC counts PI’s of commercial projects which are not PI’s of competitive projects

Other superior graduate staff
2019
Total ICS staff % ICS total
1084 625 57.66%
2020
Total ICS staff % ICS total
1114 657 58.98%
Other middle graduate or FP2 staff
2019
Total ICS staff % ICS total
336 193 57.44%
2020
Total ICS staff % ICS total
309 163 52.75%
Other research staff in platforms and support units
2019
Total ICS staff % ICS total
48 1 2.08%
2020
Total ICS staff % ICS total
51 1 1.96%
Management and administration staff
2019
Total ICS staff % ICS total
111 0 0.00%
2020
Total ICS staff % ICS total
128 0 0.00%

 

Throughputs

Competitive active research projects
2019
Num Executed budget
342 11,589,057.32€
2020
Num Executed budget
351 16,167,057.29€
Active clinical trials and other commercial research
2019
Num Billing
877 8,769,538.17€
2020
Num Billing
857 7,895,436.47€

Includes Clinical Trials, EPA and Medical Devices

Institutional projects and actions
2019
Num Total Executed budget
16 4,771,305.05€ 3,993,929.23€
2020
Num Total Executed budget
22 5,178,611.60€ 1,363,718.75€

Outputs

Publicacions
2019
Num IF Q1 D1 Leadership
1187 7124 55.3% 25.9% 38.4%
2020
Num IF Q1 D1 Leadership
1386 7802 57.4% 22.2% 39.0%

Includes original articles, reviews and scientific letters in journals indexed in JCR 2019. No ahead of print publications have been taken into account.

Leadership is first, last and/or corresponding author

Clínical guidelines
2019
Total International
41 24
2020
Total International
70 33

Includes clinical guidelines and consensus & recommendations documents, in journals indexed in JCR

Licensed patents
2019
Total portfolio New Expired
239 31 17
2020
Total portfolio New Expired
242 2 1
2019
Total portfolio New Expired
8 (5 startup + 3 spinoff) 0 0
2020
Total portfolio New Expired
9 (5 startup + 4 spinoff) 1 spinoff 0